Resources

126 Resources for

lilly

Subscribe to this listing via:
RSS
Email

Did you mean Eli Lilly & Co. (794 results)

BNET Industries

Eli Lilly & Co.: Eli Lilly is engaged primarily in the discovery, development, manufacture, and sale of pharmaceutical products. Co.'s principal products are: Neurosciences products, which includes Zyprexa®,...; Eli Lilly & Co. company page on BNET »

BNET Resources

LILLY (ELI) & COMPANY - Lilly Response to NY Times Article.: Date: March 14, 2008 For Release: Immediately Refer to: Tarra Ryker -- (317) 332-7502 mobile Marni Lemons -- (317) 532-7826 mobile Angela Sekston -- (317) 332-1593 mobile Statement from Eli Lilly and Company: Response to...; Tags: e-mail, Lilly, New York Times Co., patient; Research articles 2008-03-17
Lilly Concocts Something New for Diabetics to Worry About: "Finger Health": Lilly Concocts Something New for Diabetics to Worry About: "Finger Health"Just what I need. NOT!My fingers may be dry and a little calloused in some places but I certainly do not consider them "damaged'. The "research" time spent on this condition could be better spent making the current...; Tags: Diabetic, Finger Health, health care, Lilly, Worry About; Discussion threads 2008-04-19
LILLY (ELI) & COMPANY - State of Alaska and Lilly Settle Zyprexa Lawsuit.: Date: March 26, 2008 For Release: Immediately Refer to: (317) 532-7826 - Marni Lemons Mlemons@lilly.com (317) 332-7502 - Tarra Ryker Ryker_tarra@lilly.com ...; Tags: Eli Lilly & Co., Lilly, patient; Research articles 2008-03-26
LILLY (ELI) & COMPANY - FDA Grants Priority Review for Prasugrel.: Date: February 21, 2008 Refer to: Joedy Isert Eli Lilly and Company 317-276-5592 office 317-007-8544 cell Rich Salem Daiichi Sankyo (U.S.A.) 973-695-8330 office 973-563-1086 cell ...; Tags: cell, FDA, Lilly, patient; Research articles 2008-02-22
LILLY (ELI) & COMPANY - FDA N-A Letter for Lilly's Zyprexa.: Date: February 28, 2008 For Release: Immediately Refer to: Charlie McAtee, Eli Lilly and Company (317) 997-1627 mobile (317) 277-1566 office mcatee_charles@lilly.com David Shaffer, Eli Lilly and Company (317)...; Tags: Eli Lilly & Co., FDA, Lilly, patient, risk; Research articles 2008-02-28

LILLY (ELI) & COMPANY - Statement From Eli Lilly and Company.: Date: December 18, 2006 For Release: Immediately Refer to: Tarra Ryker (317) 276-3787 - office (317) 332-7502 - mobile Marni Lemons (317) 433-8990 - office (317) 532-7826 - mobile ...; Tags: Eli Lilly & Co., Lilly; Research articles 2006-12-18
LILLY (ELI) & COMPANY - Additional Clinical Trial Required for Ruboxistaurin.: Lilly Announces FDA Requirement of Additional Clinical Trial Before Ruboxistaurin Could Be Approved for Treatment of Diabetic Retinopathy Additional Trial Would Take Up To Five Years to Complete; Lilly Currently Evaluating Options INDIANAPOLIS, Lilly Announces FDA Requirement of Additional Clinical...; Tags: clinical trial, FDA, Lilly; Research articles 2006-09-29
LILLY (ELI) & COMPANY - Lilly Announces Approvable Letter for Arxxant.: For Release: August 18, 2006 Refer to: Marni Lemons, Lilly Sharon Corbitt, Lilly 317-433-8990 office 317-277-1574 office 317-532-7826 mobile 317-997-1206 mobile Eli Lilly...; Tags: FDA, Lilly; Research articles 2006-08-18
LILLY (ELI) & COMPANY - Dividend Declaration.: Date: October 15, 2007 For Release: Immediately Refer to: (317) 276-5795 - Mark E. Taylor Lilly Declares Fourth-Quarter Dividend ...; Tags: dividend, Eli Lilly & Co., Lilly; Research articles 2007-10-16
NOXXON Pharma AG Announces Licensing and Discovery Collaboration with Eli Lilly and Company: BERLIN -- NOXXON Pharma AG NOXXON announced today the signing of a licensing and drug discovery agreement with Eli Lilly and Company (NYSE:LLY) regarding the discovery and development of Spiegelmers([R]) for the treatment of migraine. Under the terms of the agreement NOXXON grants Lilly an exclusive worldwide license to a...; Tags: collaboration, Eli Lilly & Co., Lilly; Research articles 2008-06-11
LILLY (ELI) & COMPANY - Acquisition(s).: Date: January 29, 2007 For Release: Immediately Refer to: (317) 276-2506 - Phil Belt Lilly Announces Completion of ICOS Corporation Acquisition ...; Tags: acquisition, company, Lilly; Research articles 2007-01-30
LILLY (ELI) & COMPANY - Eskew Elected to Lilly Board of Directors.: Date: February 19, 2008 For Release: Immediately Refer to: (317) 276-2506 - Phil Belt Michael L. Eskew Elected to Lilly Board of Directors Company Also...; Tags: board, board of directors, Fisher, Lilly, United Parcel Service of America Inc.; Research articles 2008-02-19
LILLY (ELI) & COMPANY - BYETTA Treatment.: EMBARGOED UNTIL JUNE 23, 2007 at 10:00 AM Central Time/11:00 AM Eastern Time Poster Presentation - Abstract Number: 0557-P Media contacts: Lilly - Derin Denham +1 (317) 277-6749 office +1 (317) 370-1435 cell Amylin -...; Tags: Lilly, patient; Research articles 2007-06-26
LILLY (ELI) & COMPANY - Exenatide Receives Position Opinion.: For Immediate Release: September 21, 2006 Media contacts: Lilly - Derin Denham +1 (317) 277-6749 office +1 (317) 370-1435 mobile Amylin - Alice Bahner +1 (858) 642-7272 office +1 (858) 232-9072 mobile...; Tags: Lilly, patient; Research articles 2006-09-22
LILLY (ELI) & COMPANY - FDA Supports Zyprexa Long-Acting Injection.: FOR IMMEDIATE RELEASE Refer to: Charlie McAtee, Eli Lilly and Company (317) 997-1627 mobile (317) 277-1566 office mcatee_charles@lilly.com David Shaffer, Eli Lilly and Company (317) 614-5106 mobile ...; Tags: Eli Lilly & Co., FDA, Lilly, medication, patient, risk; Research articles 2008-02-07
Qantas head hails from Air NZ.: Jan 10, 2006 (Travel Digest NZ - ABIX via COMTEX) -- Grant Lilly has been appointed general manager of Qantas for New Zealand NZ and the Pacific Islands. Lilly was previously ...; Tags: Lilly, Qantas Airways Ltd.; Research articles 2006-01-10
LILLY (ELI) & COMPANY - Lilly Declares Second Quarter Dividend.: Date: April 24, 2006 For Release: Immediately Refer to: (317) 276-5795 - Terra L. Fox Lilly Declares Second-Quarter Dividend ...; Tags: dividend, Eli Lilly & Co., Lilly; Research articles 2006-04-25
LILLY (ELI) & COMPANY - Dividend Declaration.: Date: June 21, 2007 For Release: Immediately Refer to: (317) 276-5795 - Mark E. Taylor Lilly Declares Third-Quarter Dividend ...; Tags: dividend, Eli Lilly & Co., Lilly; Research articles 2007-06-22
LILLY (ELI) & COMPANY - BYETTA Study-progressive weight loss.: EMBARGOED UNTIL JUNE 25, 2007 at 3:15 PM Central Time/4:15 PM Eastern Time Oral presentation - Abstract Number: 0283-OR Media contacts: Lilly - Derin Denham +1 (317) 277-6749 office +1 (317) 370-1435 cell Amylin -...; Tags: Lilly; Research articles 2007-06-26
LILLY (ELI) & COMPANY - Lilly and Alcon Sign Marketing Collaboration.: Date: July 21, 2006 For Release: Immediately Refer to: (317) 276-5795 - Terra Fox Lilly (817) 551-8974 - Doug MacHatton Alcon ...; Tags: Lilly, marketing; Research articles 2006-07-21